ERBB2 and breast carcinoma: To evaluate the clinical significance of ACTA2, STAT1, and HER2 expression in breast cancer patients, we performed an analysis in SurvExpress (breast cancer recurrence data, 9 datasets from 7 authors) using an average for genes with multiple probesets, three risk groups determined by prognostic index median, and Cox fitting.